Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Prudential
PUK
$34.7B
| $27.7M | 0.01% |
774,660
-183,301
| -19% | -$5.63M |
|
1577
Ingevity
NGVT
$2.68B
| $27.7M | 0.01% |
366,103
-153,379
| -30% | -$9.99M |
|
1578
PUT
Medtronic
MDT
$110B
| $27.7M | 0.01% |
236,600
+113,600
| +92% | +$12.5M |
|
1579
Griffon
GFF
$4.82B
| $27.7M | 0.01% |
1,359,579
-620,411
| -31% | -$13.3M |
|
|
ACH
1580
Accendra Health
ACH
$230M
| $27.7M | 0.01% |
1,024,063
+711,769
| +228% | +$18.3M |
|
|
GAP
1581
The Gap Inc
GAP
$7.41B
| $27.7M | 0.01% |
1,371,380
-5,663,203
| -81% | -$119M |
|
1582
Lear
LEA
$8.13B
| $27.7M | 0.01% |
173,990
+47,711
| +38% | +$6.71M |
|
|
MRSN
1583
DELISTED
Mersana Therapeutics
MRSN
| $27.7M | 0.01% |
41,578
+17,731
| +74% | +$9.86M |
|
1584
Cable One
CABO
$253M
| $27.6M | 0.01% |
12,410
-1,648
| -12% | -$3.26M |
|
1585
Virtu Financial
VIRT
$4.92B
| $27.6M | 0.01% |
1,097,256
+38,074
| +4% | +$882K |
|
1586
Barclays
BCS
$95.4B
| $27.6M | 0.01% |
3,455,883
+283,829
| +9% | +$1.9M |
|
|
AIFU
1587
AIFU Inc
AIFU
$216M
| $27.6M | 0.01% |
5,728
+188
| +3% | +$1.11M |
|
1588
Heritage Financial
HFWA
$1.21B
| $27.5M | 0.01% |
1,177,602
-64,154
| -5% | -$1.44M |
|
|
PCH
1589
DELISTED
PotlatchDeltic
PCH
| $27.5M | 0.01% |
550,663
-257,120
| -32% | -$11.8M |
|
1590
Canadian Imperial Bank of Commerce
CM
$108B
| $27.5M | 0.01% |
643,328
-217,416
| -25% | -$8.85M |
|
1591
LPL Financial
LPLA
$28.2B
| $27.5M | 0.01% |
263,632
-1,820
| -0.7% | -$164K |
|
1592
Vanguard Russell 2000 ETF
VTWO
$17.8B
| $27.5M | 0.01% |
346,904
+108,956
| +46% | +$7.7M |
|
1593
Affiliated Managers Group
AMG
$9.9B
| $27.4M | 0.01% |
269,551
-18,125
| -6% | -$1.57M |
|
1594
PVH
PVH
$4.07B
| $27.4M | 0.01% |
291,717
-315,635
| -52% | -$24M |
|
1595
Hexcel
HXL
$7.9B
| $27.4M | 0.01% |
564,393
-347,660
| -38% | -$15.1M |
|
1596
Ingersoll Rand
IR
$34.9B
| $27.3M | 0.01% |
599,914
-839,415
| -58% | -$34.7M |
|
|
SINA
1597
DELISTED
Sina Corp
SINA
| $27.3M | 0.01% |
642,999
+349,918
| +119% | +$15M |
|
1598
Chemours
CC
$2.31B
| $27.2M | 0.01% |
1,099,184
+19,818
| +2% | +$472K |
|
1599
PUT
General Motors
GM
$76.4B
| $27.2M | 0.01% |
652,800
| – | – |
|
1600
TripAdvisor
TRIP
$1.24B
| $27.2M | 0.01% |
944,131
+288,632
| +44% | +$6.95M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.